EFEKTIVITAS MIKROEMULSI-GEL SELEDRI (Apium graveolens) DALAM MENURUNKAN KADAR CALPROTECTIN GCF PADA MODEL PERIODONTITIS KRONIS
DOI:
https://doi.org/10.33854/jbd.v12i1.1812Kata Kunci:
Calprotectin, Celery, Microemulsion-Gel, PeriodontitisAbstrak
Background: Calprotectin is a neutrophil secretion product that serves as one of the biomarkers for periodontal tissue inflammation. Calprotectin levels in Gingival Crevicular Fluid (GCF) are reported to increase in periodontitis conditions. Celery (Apium graveolens) contains flavonoids and polyphenols that have potential anti-inflammatory properties. The topical microemulsion-gel formulation offers optimal bioavailability of active substances when applied to periodontal pockets. Objective: To determine the effect of celery microemulsion-gel on GCF calprotectin levels in an experimental model of chronic periodontitis. Methods: This experimental study used 25 male Wistar rats (Rattus norvegicus) divided into 5 groups (n=5): healthy control group, negative control group, and three treatment groups receiving Apium graveolens microemulsion-gel at concentrations of 25%, 50%, and 100%. The chronic periodontitis model was induced using P. gingivalis. Apium graveolens microemulsion-gel (0.7 ml) was applied to the inflamed gingival sulcus for 7 days. GCF samples were collected using filter paper and calprotectin levels were measured using ELISA method. Data analysis was performed using One-Way ANOVA followed by Least Significant Difference (LSD) test. Results: GCF calprotectin levels in the Apium graveolens microemulsion-gel treatment groups were lower compared to the negative control group (p<0.05), with the lowest levels observed in the 50% concentration group. There was no significant difference between the treatment groups and the healthy control group (p>0.05). Conclusion: Apium graveolens microemulsion-gel effectively reduces GCF calprotectin levels in chronic periodontitis model, indicating an anti-inflammatory effect.Referensi
Kementerian Kesehatan RI. Hasil Riset Kesehatan Dasar (Riskesdas) 2018. Badan Penelitian dan Pengembangan Kesehatan Kementerian RI; 2018.
Newman MG, Takei HH, Klokkevold PR, Carranza FA. Newman and Carranza’s Clinical Periodontology. Elsevier; 2019.
Abdulkareem AA, Al-Taweel FB, Al-Sharqi AJB, Gul SS, Sha A, Chapple ILC. Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis. J Oral Microbiol. 2023;15(1):2197779. doi:10.1080/20002297.2023.2197779
Nishikawa Y, Kajiura Y, Lew JH, Kido J ichi, Nagata T, Naruishi K. Calprotectin Induces IL-6 and MCP-1 Production via Toll-Like Receptor 4 Signaling in Human Gingival Fibroblasts. J Cell Physiol. 2017;232(7):1862-1871. doi:10.1002/jcp.25724
Wei L, Liu M, Xiong H. Role of Calprotectin as a Biomarker in Periodontal Disease. Mediators Inflamm. 2019;2019(1):3515026. doi:10.1155/2019/3515026
George AK, Malaiappan S, Joseph B, Anil S. Calprotectin, S100A8, and S100A9: Potential Biomarkers of Periodontal Inflammation: A Scoping Review. World J Dent. 2023;14(6):559-567. doi:10.5005/jp-journals-10015-2244
Barros SP, Williams R, Offenbacher S, Morelli T. Gingival Crevicular Fluid as a Source of Biomarkers for Periodontitis. Periodontol 2000. 2016;70(1):53-64. doi:10.1111/prd.12107
Yadav R, Kanwar IL, Haider T, Pandey V, Gour V, Soni V. In situ Gel Drug Delivery System for Periodontitis: An Insight Review. Future J Pharm Sci. 2020;6(1):33. doi:10.1186/s43094-020-00053-x
Sahu G, Sharma H, Gupta A, Kaur C. Advancements in Microemulsion Based Drug Delivery Systems for Better Therapeutic Effects. Int J Pharm Sci Dev Res. 2015;1(1):008-015. doi:10.17352/ijpsdr.000003
Wulandari D, Fitrianingsih S, Mulqie L. Uji Aktivitas Antiinflamasi Ekstrak Etanol Herba Seledri (Apium graveolens L .) terhadap Tikus Wistar Jantan. Pros Farm. 2016;2(1):59-66.
Kooti W, Daraei N. A Review of the Antioxidant Activity of Celery (Apium graveolens L). J Evid-Based Complement Altern Med. 2017;22(4):1029-1034. doi:10.1177/2156587217717415
Haryani IGAD, Wedagama DM, Hervina H. The Effectiveness of Rinsing with Celery Leafs (Apium graveolens L.) Extract 10% and Chlorhexidine Gluconate 0.1% to Accelerate Post-Scaling Gingivitis Healing. Odonto Dent J. 2022;9(0):51-56. doi:10.30659/odj.9.0.51-56
Rochmawati M, Kusuma MR, Maziyyah F, et al. Antimicrobial Photodynamic Therapy with Erythrosine Photosensitizer against Immune Response in Chronic Periodontitis Model. Maj Kedokt Gigi Indones. 2023;9(2):171-180. doi:10.22146/majkedgiind.77084
Gao H, Xu J, He L, Meng H, Hou J. Calprotectin Levels in Gingival Crevicular Fluid and Serum of Patients with Chronic Periodontitis and Type 2 Diabetes Mellitus Before and After Initial Periodontal Therapy. J Periodontal Res. 2021;56(1):121-130. doi:10.1111/jre.12800
Johnstone KF, Wei Y, Bittner-Eddy PD, et al. Calprotectin (S100A8/A9) Is an Innate Immune Effector in Experimental Periodontitis. Infect Immun. 2021;89(10). doi:10.1128/iai.00122-21
Kajiura Y, Lew JH, Ikuta T, et al. Clinical Significance of GCF sIL-6R and Calprotectin to Evaluate the Periodontal Inflammation. Ann Clin Biochem. 2017;54(6):664-670. doi:10.1177/0004563216680232
Adamczyk J, Chwałowska M, Gębka N, et al. The Role of Flavonoids in The Treatment of Periodontal Diseases – Literature Review. J Pre-Clin Clin Res. 2022;16(4):153-156. doi:10.26444/jpccr/156979
Jayusman PA, Nasruddin NS, Mahamad Apandi NI, Ibrahim N, Budin SB. Therapeutic Potential of Polyphenol and Nanoparticles Mediated Delivery in Periodontal Inflammation: A Review of Current Trends and Future Perspectives. Front Pharmacol. 2022;13. doi:10.3389/fphar.2022.847702
Joshi D, Garg T, Goyal AK, Rath G. Advanced Drug Delivery Approaches Against Periodontitis. Drug Deliv. 2016;23(2):363-377. doi:10.3109/10717544.2014.935531
Basudan AM. Nanoparticle Based Periodontal Drug Delivery – A Review on Current Trends and Future Perspectives. Saudi Dent J. 2022;34(8):669-680. doi:10.1016/j.sdentj.2022.09.006
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).


